216 related articles for article (PubMed ID: 22930795)
1. Thalidomide-associated thrombosis in the treatment of HIV-associated severe aphthous disease: a case report and review of the literature.
Hodowanec AC; Han A; Barker DE; Rubinstein PG; Max B
J Int Assoc Physicians AIDS Care (Chic); 2012; 11(6):345-7. PubMed ID: 22930795
[TBL] [Abstract][Full Text] [Related]
2. Refractory aphthous ulceration treated with thalidomide: a report of 10 years' clinical experience.
Cheng S; Murphy R
Clin Exp Dermatol; 2012 Mar; 37(2):132-5. PubMed ID: 22007681
[TBL] [Abstract][Full Text] [Related]
3. [Deep vein thrombosis and pulmonary embolism in a patient with aphtosis treated with thalidomide].
Esteve E; Legac E
Ann Dermatol Venereol; 2001 Feb; 128(2):148-9. PubMed ID: 11275595
[No Abstract] [Full Text] [Related]
4. Current role of thalidomide in HIV-positive patients with recurrent aphthous ulcerations.
Shetty K
Gen Dent; 2007; 55(6):537-42. PubMed ID: 18050580
[TBL] [Abstract][Full Text] [Related]
5. Thalidomide for treatment of oral aphthous ulcers in patients with human immunodeficiency virus: case report and review.
Ball SC; Sepkowitz KA; Jacobs JL
Am J Gastroenterol; 1997 Jan; 92(1):169-70. PubMed ID: 8995965
[No Abstract] [Full Text] [Related]
6. Deep vein thrombosis occurring on treatment of patients receiving thalidomide with erythropoietin.
Chennuru S; Baumann MA
Intern Med J; 2007 Jul; 37(7):506-7. PubMed ID: 17547733
[No Abstract] [Full Text] [Related]
7. Thalidomide in low intermittent doses does not prevent recurrence of human immunodeficiency virus-associated aphthous ulcers.
Jacobson JM; Greenspan JS; Spritzler J; Fox L; Fahey JL; Jackson JB; Chernoff M; Wohl DA; Pulvirenti JJ; Hooton TM; Shikuma C
J Infect Dis; 2001 Jan; 183(2):343-346. PubMed ID: 11120935
[TBL] [Abstract][Full Text] [Related]
8. Thalidomide therapy and deep venous thrombosis in multiple myeloma.
Rajkumar SV
Mayo Clin Proc; 2005 Dec; 80(12):1549-51. PubMed ID: 16350272
[No Abstract] [Full Text] [Related]
9. Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group.
Jacobson JM; Greenspan JS; Spritzler J; Ketter N; Fahey JL; Jackson JB; Fox L; Chernoff M; Wu AW; MacPhail LA; Vasquez GJ; Wohl DA
N Engl J Med; 1997 May; 336(21):1487-93. PubMed ID: 9154767
[TBL] [Abstract][Full Text] [Related]
10. Thalidomide: an experience in therapeutic outcome and adverse reactions.
Sharma NL; Sharma VC; Mahajan VK; Shanker V; Ranjan N; Gupta M
J Dermatolog Treat; 2007; 18(6):335-40. PubMed ID: 17852637
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human erythropoietin and the risk of thrombosis in patients receiving thalidomide for multiple myeloma.
Galli M; Elice F; Crippa C; Comotti B; Rodeghiero F; Barbui T
Haematologica; 2004 Sep; 89(9):1141-2. PubMed ID: 15377478
[TBL] [Abstract][Full Text] [Related]
12. Arterial and venous thrombotic complications with thalidomide in multiple myeloma.
Alkindi S; Dennison D; Pathare A
Arch Med Res; 2008 Feb; 39(2):257-8. PubMed ID: 18164975
[No Abstract] [Full Text] [Related]
13. Thalidomide for aphthous ulcers in HIV infection.
Birnkrant D
N Engl J Med; 1997 Oct; 337(15):1086-7. PubMed ID: 9324641
[No Abstract] [Full Text] [Related]
14. Deep vein thrombosis in a patient with lepromatous leprosy receiving thalidomide to treat leprosy reaction.
Hebe Petiti-Martin G; Villar-Buill M; de la Hera I; Fuertes L; Burgués-Calderón M; Rivera-Díaz R; Vanaclocha F
Actas Dermosifiliogr; 2013 Jan; 104(1):67-70. PubMed ID: 22705284
[TBL] [Abstract][Full Text] [Related]
15. Arterial thrombosis with immunomodulatory derivatives in the treatment of multiple myeloma: a single-center case series and review of the literature.
Martin MG; Vij R
Clin Lymphoma Myeloma; 2009 Aug; 9(4):320-3. PubMed ID: 19717384
[TBL] [Abstract][Full Text] [Related]
16. Deep venous thrombosis and thalidomide therapy for multiple myeloma.
Osman K; Comenzo R; Rajkumar SV
N Engl J Med; 2001 Jun; 344(25):1951-2. PubMed ID: 11419443
[No Abstract] [Full Text] [Related]
17. The role of aspirin in the prevention of thrombotic complications of thalidomide and anthracycline-based chemotherapy for multiple myeloma.
Baz R; Li L; Kottke-Marchant K; Srkalovic G; McGowan B; Yiannaki E; Karam MA; Faiman B; Jawde RA; Andresen S; Zeldis J; Hussein MA
Mayo Clin Proc; 2005 Dec; 80(12):1568-74. PubMed ID: 16342649
[TBL] [Abstract][Full Text] [Related]
18. Low incidence of thromboembolism in relapsed/refractory myeloma patients treated with thalidomide without thromboprophylaxis in Taiwan.
Wu SY; Yeh YM; Chen YP; Su WC; Chen TY
Ann Hematol; 2012 Nov; 91(11):1773-8. PubMed ID: 22706703
[TBL] [Abstract][Full Text] [Related]
19. Thalidomide and recurrent aphthous stomatitis: a follow-up study.
Bonnetblanc JM; Royer C; Bedane C
Dermatology; 1996; 193(4):321-3. PubMed ID: 8993957
[TBL] [Abstract][Full Text] [Related]
20. Thalidomide's comeback.
Vazquez E
Posit Aware; 1998; 9(4):53-4. PubMed ID: 11365634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]